CAPONE, EMILY
 Distribuzione geografica
Continente #
NA - Nord America 2.138
AS - Asia 1.238
EU - Europa 1.145
Continente sconosciuto - Info sul continente non disponibili 184
SA - Sud America 169
AF - Africa 36
OC - Oceania 1
Totale 4.911
Nazione #
US - Stati Uniti d'America 2.076
SG - Singapore 600
IT - Italia 396
CN - Cina 247
VN - Vietnam 159
IE - Irlanda 158
BR - Brasile 137
RU - Federazione Russa 127
SE - Svezia 96
DE - Germania 83
IN - India 56
GB - Regno Unito 48
FR - Francia 47
FI - Finlandia 46
TR - Turchia 41
UA - Ucraina 37
BD - Bangladesh 34
CA - Canada 34
NL - Olanda 22
HK - Hong Kong 21
ZA - Sudafrica 17
AR - Argentina 15
PL - Polonia 14
AT - Austria 13
BE - Belgio 13
IQ - Iraq 10
ES - Italia 9
JP - Giappone 9
MX - Messico 9
AE - Emirati Arabi Uniti 8
KR - Corea 8
CH - Svizzera 7
EG - Egitto 7
LT - Lituania 6
UZ - Uzbekistan 6
GR - Grecia 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
JO - Giordania 4
VE - Venezuela 4
CR - Costa Rica 3
HR - Croazia 3
ID - Indonesia 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
PE - Perù 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 4.728
Città #
Singapore 439
San Jose 244
Chandler 207
Dublin 156
Ashburn 152
The Dalles 82
Beijing 75
Dallas 73
Jacksonville 71
Santa Clara 67
Council Bluffs 66
Los Angeles 59
New York 58
Pescara 55
Princeton 53
Chieti 50
Ho Chi Minh City 45
Ann Arbor 43
Munich 35
Boardman 29
Altamura 27
Hanoi 27
Dong Ket 22
Buffalo 21
Dearborn 20
Columbus 19
Hong Kong 18
Izmir 18
Nanjing 18
Wilmington 18
Lappeenranta 17
Milan 17
Atlanta 16
Denver 16
Montreal 16
Hefei 15
Phoenix 15
Tongling 15
Turku 14
Brussels 13
Rome 13
Frankfurt am Main 12
Johannesburg 12
Moscow 12
Stockholm 12
Warsaw 12
Brooklyn 11
Houston 11
L’Aquila 11
Nuremberg 11
Orem 11
Redondo Beach 11
São Paulo 11
Chennai 9
Da Nang 9
Helsinki 9
Pune 9
Southend 8
Tokyo 8
Cambridge 7
Falls Church 7
Haiphong 7
Hebei 7
London 7
Mumbai 7
Poplar 7
Seoul 7
Chicago 6
Dubai 6
Rio de Janeiro 6
Seattle 6
Tashkent 6
Vienna 6
Washington 6
Cairo 5
Finale Ligure 5
Macerata 5
Nanchang 5
Ninh Bình 5
Norwalk 5
Perugia 5
Salvador 5
Shanghai 5
St Louis 5
Zurich 5
Amman 4
Baghdad 4
Belo Horizonte 4
Castignano 4
Cleveland 4
Collecorvino 4
Providence 4
Putignano 4
Querétaro 4
Redwood City 4
San Francisco 4
Shijiazhuang 4
Toronto 4
Woodbridge 4
Zhengzhou 4
Totale 2.836
Nome #
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 238
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 224
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 186
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 175
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 172
ABCC3 is a novel target for the treatment of pancreatic cancer 170
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 156
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 154
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 154
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 154
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 153
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 141
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 137
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 135
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 134
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 132
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 130
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 128
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 125
Normal breathing releases SARS-CoV-2 into the air 123
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 119
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 116
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 113
Antibody-drug conjugates: The new frontier of chemotherapy 113
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 113
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 111
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 110
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 106
HER-3: Hub for escape mechanisms 97
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 95
Endosialin-binding antibody 95
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 94
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 84
MYC regulates metabolism through vesicular transfer of glycolytic kinases 84
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 83
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 76
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 68
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 65
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 48
Totale 4.911
Categoria #
all - tutte 20.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022166 0 0 4 25 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/20251.022 34 180 162 53 21 39 42 48 128 69 152 94
2025/20261.964 154 70 138 218 228 131 382 97 180 206 107 53
2026/2027301 56 214 31 0 0 0 0 0 0 0 0 0
Totale 4.911